
中国和印度可以帮助阻止“疫苗民族主义”吗?
印度和中国是占据全球新冠病毒疫苗产能一半以上的重要生产国,中印双方必须做出更多的努力,才能与"新冠病毒疫苗全球实施计划"(COVAX)共享疫苗供应。
Zubaida Bai is a thought leader and a health-solutions innovator for underserved women and girls globally. Building on her expertise as a mechanical engineer and a product designer, Zubaida, a mother of three, is the founder and CEO of ayzh (pronounced “eyes”), a social enterprise that began with janma, a $3 Clean Birth Kit in a Purse. ayzh is a global business providing reproductive health products and services for over one million women and girls in underdeveloped countries.
Zubaida has been recognized as a Young Global Leader by the World Economic Forum, a Maternal Health Champion by Ashoka, a TED Speaker, Fellow, and Resident, and a Sustainable Development Goals (SDGs) Pioneer by the United Nations Global Compact (UNGC).
Zubaida is also the co-founder of Happy Woman Foundation with a vision of catalyzing the next wave of changes that enable women to achieve their entrepreneurial dreams.
印度和中国是占据全球新冠病毒疫苗产能一半以上的重要生产国,中印双方必须做出更多的努力,才能与"新冠病毒疫苗全球实施计划"(COVAX)共享疫苗供应。
India and China, produce over half global capacity of COVID-19 vaccines but must improve supply to COVAX – fair distribution is quickest route to recovery.
Lockdowns could have unintended consequences from which poorer nations might not recover. Could countries like Sri Lanka and Malaysia show a better way?
Mothers have mastered resilience, creativity, people management and complex problem solving. So why are they routinely overlooked by investors?